Karan Gupta, MD
Critical Care Medicine · Las Vegas, NVNPI 1093157836
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (49.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 64.9% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2022 at $8,915 and has fallen 64.5% since, to $3,166 in 2025. Among critical care medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 431 payments — averaging $67.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$19K
- AstraZeneca$3K
- Actelion Pharmaceuticals US, Inc.$2K
- GSK$971
- Merit Medical Systems Inc$793
- Regeneron Healthcare Solutions, Inc.$770
- plus $3K from 30 others
What the payments were for
- Speaking & faculty fees$1,0003%
- Travel & lodging$2,90010%
- Food & beverage$10,95037%
- Education$14,41249%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 38 | $18,982 |
| AstraZeneca | 105 | $2,909 |
| Actelion Pharmaceuticals US, Inc. | 43 | $1,624 |
| GSK | 58 | $971 |
| Merit Medical Systems Inc | 8 | $793 |
| Regeneron Healthcare Solutions, Inc. | 30 | $770 |
| Sanofi | 27 | $566 |
| Amgen | 20 | $363 |
| Merck | 16 | $362 |
| Boston Scientific | 3 | $341 |
| Grifols USA, LLC | 10 | $263 |
| E.r. Squibb & Sons, L.L.C. | 8 | $145 |
| La Jolla Pharmaceutical Company | 7 | $139 |
| Viatris Specialty LLC | 5 | $111 |
| Electromed, Inc. | 14 | $105 |
| AbbVie | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| Inogen, Inc. | 3 | $75 |
| Harmony Biosciences LLC | 3 | $73 |
| Mylan Specialty L.p. | 3 | $71 |
| Edwards Lifesciences | 1 | $57 |
| Paratek Pharmaceuticals, Inc. | 3 | $42 |
| Novo Nordisk | 2 | $39 |
| Novartis | 2 | $37 |
| Boehringer Ingelheim | 2 | $33 |
| Abiomed | 2 | $31 |
| Bayer | 1 | $25 |
| Shionogi Inc | 1 | $25 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $24 |
| Pfizer | 1 | $24 |
| Pulmonx Corporation | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| ZOLL Respicardia, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$11,121
- ION$6,000
- DA VINCI SP$1,000
- FASENRA$785
- BREZTRI$611
- AIRSUPRA$557
- UPTRAVI$399
- OPSUMIT$399
- AERO Stent & del system$350
- AEROMini Fully Covered Tracheobronchial Stent$339
- SYMBICORT$225
- GENERAL VASCULAR INTERVENTION$168
- IMFINZI$123
- OPTICROSS$112
How this compares
$29,262 in reported general payments places this provider in the 95th percentile of 68 critical care medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 20 | $249,250 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 153 | $118,053 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 83 | $58,755 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 76 | $42,367 |
| Breo ElliptaFluticasone/Vilanterol | 76 | $27,876 |
| EliquisApixaban | 13 | $7,461 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,271 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 192 | $5,765 |
| Arnuity ElliptaFluticasone Furoate | 29 | $5,689 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $3,601 |
| Roflumilast | 23 | $3,181 |
| Ventolin HfaAlbuterol Sulfate | 53 | $2,852 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $2,847 |
| Tiotropium Bromide | 12 | $2,777 |
| Montelukast Sodium | 163 | $1,059 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat | $33 | $255,52232 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta | $971 | $134,687264 claims |
| AstraZenecaBreztri Aerosphere | $2,909 | $118,053153 claims |
| PfizerEliquis | $24 | $7,46113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 68 critical care medicine providers in Nevada.
Other critical care medicine in Las Vegas
- Joaquim TavaresLas Vegas$21K
- Ghulam AftabLas Vegas$7K
- Hany GhaliLas Vegas$4K
- Spandan PatelLas Vegas$2K
- Zoltan HorvathLas Vegas$2K
- Michael GaleLas Vegas$2K
- Prashant GundreLas Vegas$1K
- John KotLas Vegas$1K
- Mohamed AlibakhietLas Vegas$1K
- Anaam ShaikhLas Vegas$816
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.